Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Adverse Drug Reaction Reporting Systems | 14 | 2020 | 694 | 2.08 | Why? |
| Epidemiologic Methods | 12 | 2017 | 392 | 1.97 | Why? |
| Data Collection | 13 | 2017 | 1769 | 1.07 | Why? |
| Viral Vaccines | 9 | 2020 | 7560 | 0.96 | Why? |
| Immunization | 4 | 2019 | 2019 | 0.88 | Why? |
| Vaccines, Attenuated | 3 | 2020 | 952 | 0.78 | Why? |
| Vaccination | 18 | 2021 | 19050 | 0.78 | Why? |
| Pregnant Women | 3 | 2019 | 2535 | 0.57 | Why? |
| Ebolavirus | 1 | 2020 | 834 | 0.49 | Why? |
| Hemorrhagic Fever, Ebola | 2 | 2020 | 1475 | 0.45 | Why? |
| Vaccines | 6 | 2020 | 3692 | 0.44 | Why? |
| Drug Approval | 1 | 2020 | 1325 | 0.43 | Why? |
| Patient Safety | 3 | 2020 | 4885 | 0.37 | Why? |
| Product Surveillance, Postmarketing | 2 | 2021 | 189 | 0.36 | Why? |
| Biomedical Research | 2 | 2020 | 5270 | 0.35 | Why? |
| Patient Selection | 2 | 2020 | 4560 | 0.35 | Why? |
| Clinical Trials as Topic | 4 | 2021 | 7330 | 0.32 | Why? |
| Immunization Programs | 1 | 2019 | 2006 | 0.31 | Why? |
| Pregnancy | 16 | 2020 | 23879 | 0.29 | Why? |
| Guidelines as Topic | 2 | 2017 | 2844 | 0.29 | Why? |
| Risk Assessment | 6 | 2020 | 25439 | 0.26 | Why? |
| Gestational Age | 2 | 2019 | 1488 | 0.24 | Why? |
| Health Information Interoperability | 1 | 2021 | 80 | 0.21 | Why? |
| Pharmacoepidemiology | 1 | 2021 | 84 | 0.21 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.21 | Why? |
| Gambia | 1 | 2019 | 145 | 0.19 | Why? |
| Africa, Western | 1 | 2020 | 363 | 0.19 | Why? |
| Ebola Vaccines | 1 | 2020 | 126 | 0.19 | Why? |
| Drug Evaluation, Preclinical | 2 | 2020 | 3347 | 0.18 | Why? |
| Developing Countries | 3 | 2019 | 4283 | 0.18 | Why? |
| International Cooperation | 3 | 2021 | 3436 | 0.18 | Why? |
| Failure to Thrive | 1 | 2017 | 33 | 0.18 | Why? |
| Maternal-Child Health Services | 1 | 2019 | 124 | 0.17 | Why? |
| Pregnancy, Ectopic | 1 | 2017 | 82 | 0.16 | Why? |
| Obstetric Labor Complications | 1 | 2017 | 119 | 0.16 | Why? |
| Respiratory Distress Syndrome, Newborn | 1 | 2017 | 124 | 0.16 | Why? |
| Fetal Development | 1 | 2017 | 173 | 0.16 | Why? |
| Infant, Low Birth Weight | 1 | 2017 | 243 | 0.16 | Why? |
| Microcephaly | 1 | 2017 | 181 | 0.15 | Why? |
| Immunogenicity, Vaccine | 3 | 2020 | 4624 | 0.15 | Why? |
| Fetal Diseases | 1 | 2017 | 182 | 0.15 | Why? |
| Fetal Growth Retardation | 1 | 2017 | 217 | 0.15 | Why? |
| Immunization Schedule | 2 | 2021 | 1305 | 0.14 | Why? |
| Congenital Abnormalities | 1 | 2016 | 170 | 0.14 | Why? |
| Truth Disclosure | 1 | 2017 | 196 | 0.14 | Why? |
| Vaccines, DNA | 1 | 2020 | 871 | 0.13 | Why? |
| Infant, Newborn, Diseases | 1 | 2017 | 394 | 0.13 | Why? |
| Government Regulation | 1 | 2020 | 842 | 0.12 | Why? |
| Vaccines, Inactivated | 1 | 2020 | 1562 | 0.12 | Why? |
| Infant, Newborn | 9 | 2019 | 23105 | 0.12 | Why? |
| Vaccination Refusal | 1 | 2021 | 831 | 0.12 | Why? |
| Diabetes, Gestational | 1 | 2017 | 426 | 0.12 | Why? |
| Abortion, Spontaneous | 1 | 2017 | 776 | 0.11 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.11 | Why? |
| Humans | 34 | 2021 | 930598 | 0.11 | Why? |
| Health Facilities | 1 | 2019 | 1230 | 0.10 | Why? |
| Standard of Care | 1 | 2017 | 1297 | 0.10 | Why? |
| Maternal Health Services | 1 | 2019 | 808 | 0.10 | Why? |
| Informed Consent | 1 | 2017 | 890 | 0.10 | Why? |
| Double-Blind Method | 1 | 2020 | 5988 | 0.10 | Why? |
| South Africa | 1 | 2019 | 3326 | 0.09 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2020 | 3231 | 0.08 | Why? |
| Female | 16 | 2020 | 380317 | 0.08 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.08 | Why? |
| Zika Virus | 1 | 2019 | 1924 | 0.08 | Why? |
| Brain Diseases | 1 | 2017 | 1463 | 0.07 | Why? |
| Health Resources | 1 | 2019 | 2592 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2019 | 1920 | 0.07 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.07 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.07 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.07 | Why? |
| Communicable Diseases | 1 | 2019 | 2148 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.06 | Why? |
| Influenza Vaccines | 1 | 2019 | 2941 | 0.06 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.06 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.06 | Why? |
| Pacific Islands | 1 | 2021 | 152 | 0.05 | Why? |
| Placebo Effect | 1 | 2021 | 108 | 0.05 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.05 | Why? |
| Plant Leaves | 1 | 2021 | 233 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.05 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.05 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.05 | Why? |
| Epidemics | 1 | 2019 | 6407 | 0.05 | Why? |
| Registries | 1 | 2018 | 12327 | 0.05 | Why? |
| Adult | 3 | 2020 | 244371 | 0.04 | Why? |
| Meningitis, Meningococcal | 1 | 2018 | 114 | 0.04 | Why? |
| Societies, Scientific | 1 | 2020 | 414 | 0.04 | Why? |
| Pharmacovigilance | 1 | 2021 | 501 | 0.04 | Why? |
| Antibody-Dependent Enhancement | 1 | 2020 | 413 | 0.04 | Why? |
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2016 | 92 | 0.04 | Why? |
| Animals | 3 | 2020 | 78931 | 0.04 | Why? |
| Uganda | 1 | 2019 | 1057 | 0.04 | Why? |
| Geography | 1 | 2021 | 1801 | 0.03 | Why? |
| Respiratory Syncytial Viruses | 1 | 2018 | 612 | 0.03 | Why? |
| Technology | 1 | 2020 | 812 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Prospective Studies | 1 | 2019 | 43301 | 0.03 | Why? |
| Asia | 1 | 2021 | 2399 | 0.03 | Why? |
| Child | 2 | 2020 | 70012 | 0.03 | Why? |
| Genetic Vectors | 1 | 2020 | 1600 | 0.03 | Why? |
| Public Opinion | 1 | 2020 | 1165 | 0.03 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.03 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.02 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2018 | 1234 | 0.02 | Why? |
| Malaria | 1 | 2018 | 1097 | 0.02 | Why? |
| World Health Organization | 1 | 2021 | 4213 | 0.02 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.02 | Why? |
| Retrospective Studies | 1 | 2019 | 105322 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Dengue | 1 | 2018 | 1565 | 0.02 | Why? |
| Databases, Factual | 1 | 2021 | 6248 | 0.02 | Why? |
| Internet | 1 | 2020 | 6204 | 0.01 | Why? |
| Middle Aged | 1 | 2020 | 270681 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Male | 1 | 2020 | 367725 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.01 | Why? |
| Pregnancy Complications, Infectious | 1 | 2016 | 11559 | 0.01 | Why? |
Kochhar's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(73)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_